Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130201009M |
| Application |
Cancer Marker |
The kit has been designed for the quantitative determination of Cancer Antigen 125 in human serum. The method can be used for samples over the range of 2.0-1,200 U /ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
Fast, Reliable Quantitative CA 125 TestingGain confidence in CA 125 antigen determination with the Snibe MAGLUMI CA 125 (CLIA) kit. Leveraging advanced chemiluminescence technology, this kit offers clinicians rapid, automated analysis with high accuracy and reproducibility, ideal for professional laboratories. Its design supports routine cancer biomarker monitoring with user-friendly operation and robust performance across multiple instruments in the MAGLUMI range.
Designed for Professional Laboratory UseThe MAGLUMI CA 125 reagent kit is developed for in vitro diagnostic use exclusively in clinical laboratory environments. Compatible with Snibe's MAGLUMI series analyzers, it provides efficient workflow integration, color-coded vials for reduced errors, and an onboard reagent stability of up to 28 days. Careful engineering and traceable calibration ensure dependable measurement across various sample types.
FAQ's of Snibe MAGLUMI CA 125 (CLIA):
Q: How do I use the Snibe MAGLUMI CA 125 (CLIA) kit for CA 125 testing?
A: The kit is used with MAGLUMI analyzers to quantitatively detect CA 125 antigen in human serum or plasma samples. After calibration and sample loading, the automated system processes the test using chemiluminescence immunoassay technology, delivering results in approximately 40 minutes.
Q: What samples can be analyzed with this reagent kit?
A: The MAGLUMI CA 125 kit is validated for use with human serum or plasma samples collected using EDTA, citrate, or heparin anticoagulants, ensuring flexibility in sample collection in clinical laboratories.
Q: When should CA 125 testing be performed using this kit?
A: This kit is suited for clinicians who are monitoring or diagnosing conditions associated with elevated CA 125 levels, particularly ovarian cancer, as well as for ongoing patient management and evaluation during therapy.
Q: Where can the MAGLUMI CA 125 (CLIA) kit be used?
A: The reagent kit is intended for in vitro diagnostic use only in a professional clinical laboratory setting and is compatible with Snibe MAGLUMI series analyzers such as the MAGLUMI 800, 1000, 2000, and X8.
Q: What is the benefit of using this chemiluminescence-based kit?
A: The CLIA-based assay provides excellent sensitivity and specificity for CA 125 detection, a broad measuring range (typically 0.5 - 500 U/mL), rapid turnaround time, and multi-point calibration traceable to WHO standards, enhancing the reliability of patient results.
Q: How long can I use the reagents after opening the kit?
A: Once opened and placed on board the analyzer, reagents are typically stable for up to 28 days. Always check the specific Instructions for Use (IFU) provided with each kit lot for exact details.
Q: What are the recommended storage conditions for the kit?
A: Store the reagents at 2-8C, avoiding freezing, to preserve performance and shelf life. Unopened kits are generally valid for 12-18 months, depending on the lot; always refer to the package for relevant expiration information.